MEDGm vs Noom
MEDGm and Noom both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
MEDGm
Best for: month-to-month compounded semaglutide at $179 with the partner pharmacies named
Visit MEDGm →
If you are choosing between MEDGm and Noom, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. MEDGm leads our six-part score, 7.4 to 6.9.
MEDGm vs Noom price
MEDGm and Noom start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $179 a month; tirzepatide is cheaper at MEDGm ($279 a month vs $349 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, MEDGm prices compounded injections, while Noom prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
MEDGm says it treats patients nationwide but does not list states, and Noom does not publish where it ships.
Pricing
MEDGm
$179 is the month-to-month rate, struck through from $299 at MEDGm's own checkout. The prepay tiers are not all cheaper: 3 months costs $249/mo and 6 months $219/mo, both more than paying monthly. Only the 12-month tier undercuts it, at $169/mo billed as a single $2,028 charge.
$249/mo for the oral dissolving tablet, sold as a $70 upgrade on the semaglutide injection and struck through from $369. Prepay tiers run $319/mo for 3 months, $289/mo for 6, and $239/mo for 12 billed as a single $2,868 charge.
$279/mo, struck through from $399, and not advertised at any price on the public pages. Prepay tiers run $349/mo for 3 months, $319/mo for 6 billed as $1,914, and $269/mo for 12 billed as $3,228 - the 3 and 6-month tiers again cost more than paying monthly.
The $99 buys the membership only. MEDGm does not publish what the Zepbound itself costs and lists availability as subject to change. Its signup flow sells compounded medication only.
The $99 buys the membership only. MEDGm does not publish what the Wegovy itself costs and lists availability as subject to change. Wegovy is not offered in its signup flow.
The $171 buys the membership only. MEDGm does not publish what the Ozempic itself costs and lists availability as subject to change. Ozempic is not offered in its signup flow.
Noom
The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.
The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.
What each price covers
Both prices cover the clinician visit.
MEDGm's price also covers the medication itself and shipping, which Noom does not claim.
Noom's price also covers coaching, which MEDGm does not claim.
MEDGm is silent on lab work and coaching.
Noom is silent on the medication itself, shipping and lab work.
That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.
MEDGm
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, MEDGm scores 7.4 and Noom 6.9 out of 10.
MEDGm is stronger on trust & safety (8.0 vs 6.5) and support (7.0 vs 4.0).
Value, effectiveness, user experience and accessibility are within half a point.
MEDGm
7.4/10
Noom
6.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither MEDGm nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | MEDGm | Noom |
|---|---|---|
| Starting Price | $179/mo | $179/mo |
| Features | ✓8 features | 2 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About MEDGm
MEDGm is a Delaware-registered telehealth platform selling compounded semaglutide and tirzepatide, with the clinical side run by OpenLoop Health providers. Month-to-month pricing is $179 for the semaglutide injection, $249 for an oral dissolving tablet and $279 for tirzepatide, each including the consultation, medication and shipping. Neither the drug name nor the plan ladder appears until you submit your name, email and phone. Brand Wegovy, Zepbound and Ozempic are advertised separately on a membership-plus-drug-cost basis.
Read our full MEDGm review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
MEDGm
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $279 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
- We found no FDA warning letters issued to MEDGm
Watch-outs
- Confirm it serves your state before you start the intake
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Noom
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
MEDGm wins this one, 7.4 to 6.9, above all for month-to-month compounded semaglutide at $179 with the partner pharmacies named. Noom fits better if coaching bundled into the price rather than sold separately is your priority.
Choose MEDGm if…
You want month-to-month compounded semaglutide at $179 with the partner pharmacies named and an opening price near $179 a month.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $179 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →MEDGm vs Noom: FAQ
Close alternatives to MEDGm and Noom
- MEDGm vs Nurx
- MEDGm vs Bodybuilding Health+
- MEDGm vs AbundRX
- Noom vs GOAL.MD
- Noom vs Vaylen
- Noom vs DudeMeds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.